These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Paget's disease of bone: recent advances in therapy. Canalis EM; Mundy GR; Raisz LG Conn Med; 1977 Feb; 41(2):79-83. PubMed ID: 138526 [No Abstract] [Full Text] [Related]
45. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?]. Davoine GA; Jung A; Courvoisier B Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879 [TBL] [Abstract][Full Text] [Related]
46. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate]. Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634 [No Abstract] [Full Text] [Related]
47. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. Smith R; Russell RG; Bishop MC; Woods CG; Bishop M Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518 [No Abstract] [Full Text] [Related]
48. New modes of therapy for Paget's disease of bone. Kammerman S Am J Med Sci; 1972 May; 263(5):393-5. PubMed ID: 4261723 [No Abstract] [Full Text] [Related]
49. Paget's disease of bone. Concepts in pathogenesis and treatment with mithramycin. Ryan WG Proc Inst Med Chic; 1972 Mar; 29(2):81. PubMed ID: 4259573 [No Abstract] [Full Text] [Related]
50. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study]. Eisinger J; Laponche AM; Ouaniche J Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204 [No Abstract] [Full Text] [Related]
53. Focal osteolysis as a complication of therapy for Paget's disease: case report. Zander DR; Lander P; Bégin LR; Hadjipavlou AG Can Assoc Radiol J; 1998 Apr; 49(2):102-4. PubMed ID: 9561012 [No Abstract] [Full Text] [Related]
54. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Nuti R; Turchetti V; Righi G; Vattimo A Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555 [TBL] [Abstract][Full Text] [Related]
55. Editorial: Treatment of Paget's disease. Med J Aust; 1974 Apr; 1(15):554-5. PubMed ID: 4276276 [No Abstract] [Full Text] [Related]
56. Paget's disease of bone--current thinking and management. Hughes S; Peel-White AL; Peterson CK J Manipulative Physiol Ther; 1992 May; 15(4):242-9. PubMed ID: 1321871 [TBL] [Abstract][Full Text] [Related]
57. [Treatment of Paget's disease of bone]. Meunier PJ; Delmas P Rev Prat; 1980 Apr; 30(23):1501-2, 1505-6, 1509-10 passim. PubMed ID: 6446136 [No Abstract] [Full Text] [Related]
58. Paget disease: a review of current knowledge. Frame B; Marel GM Radiology; 1981 Oct; 141(1):21-4. PubMed ID: 6457311 [TBL] [Abstract][Full Text] [Related]
59. [Clinical and metabolic effects of mithramycin and glucagon in the treatment of Paget's disease]. Hadjipavlou AG; Danais S; Greenwood F; Siller TN; Tsoukas GM Union Med Can; 1978 Sep; 107(9):849-56. PubMed ID: 151960 [No Abstract] [Full Text] [Related]
60. Paget's disease of bone: diagnosis and management. Kanis JA; Evanson JM; Russell RG Metab Bone Dis Relat Res; 1981; 3(4-5):219-30. PubMed ID: 6220190 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]